NO20034556L - Imidazotriazinon-holdige sammensetninger for nasal administrering - Google Patents

Imidazotriazinon-holdige sammensetninger for nasal administrering

Info

Publication number: NO20034556L
Authority: NO; Norway
Prior art keywords: imidazotriazinone; containing compositions; nasal administration; nasal; administration
Prior art date: 2001-04-12

Application number

NO20034556A

Other languages

English (en)

Norwegian (no)

Other versions

NO20034556D0 (no

Inventor

Peter Serno

Andreas Ohm

Wolfgang Barth

Richard-Josef Bauer

Hans-Martin Siefert

Dieter Zimmer

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2003-10-10

Publication date

2003-12-10

2003-10-10 Application filed by Bayer Ag filed Critical Bayer Ag

2003-10-10 Publication of NO20034556D0 publication Critical patent/NO20034556D0/no

2003-12-10 Publication of NO20034556L publication Critical patent/NO20034556L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Anesthesiology (AREA)
Pulmonology (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20034556A 2001-04-12 2003-10-10 Imidazotriazinon-holdige sammensetninger for nasal administrering NO20034556L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10118306A DE10118306A1 (de)	2001-04-12	2001-04-12	Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
PCT/EP2002/003663 WO2002083674A2 (de)	2001-04-12	2002-04-03	Imidazotriazinonhaltige zusammensetzungen zur nasalen applikation

Publications (2)

Publication Number	Publication Date
NO20034556D0 NO20034556D0 (no)	2003-10-10
NO20034556L true NO20034556L (no)	2003-12-10

Family

ID=7681379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034556A NO20034556L (no)	2001-04-12	2003-10-10	Imidazotriazinon-holdige sammensetninger for nasal administrering

Country Status (25)

Country	Link
US (2)	US6740306B2 (sk)
EP (1)	EP1381368A2 (sk)
JP (1)	JP2004525968A (sk)
KR (1)	KR20030087072A (sk)
CN (1)	CN1537004A (sk)
AR (1)	AR035821A1 (sk)
BG (1)	BG108245A (sk)
BR (1)	BR0208813A (sk)
CA (1)	CA2443639A1 (sk)
CZ (1)	CZ20032752A3 (sk)
DE (1)	DE10118306A1 (sk)
DO (1)	DOP2002000373A (sk)
EC (1)	ECSP034795A (sk)
EE (1)	EE200300501A (sk)
GT (1)	GT200200070A (sk)
HU (1)	HUP0303877A3 (sk)
IL (1)	IL158255A0 (sk)
MX (1)	MXPA03009314A (sk)
NO (1)	NO20034556L (sk)
PE (1)	PE20021035A1 (sk)
PL (1)	PL363033A1 (sk)
RU (1)	RU2003133143A (sk)
SK (1)	SK12682003A3 (sk)
UY (1)	UY27256A1 (sk)
WO (1)	WO2002083674A2 (sk)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040152700A1 (en) *	2001-05-09	2004-08-05	Ulrich Niewohner	Novel use of 2-phenyl-substituted imidazotriazinones
DE102004023069A1 (de) *	2004-05-11	2005-12-08	Bayer Healthcare Ag	Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
JP4966204B2 (ja) *	2004-12-23	2012-07-04	ロックスロファーマ，インコーポレイテッド	ケトロラクの鼻腔内投与のための治療用組成物
DE102005001989A1 (de) *	2005-01-15	2006-07-20	Bayer Healthcare Ag	Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009241A1 (de) *	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102005009240A1 (de) *	2005-03-01	2006-09-07	Bayer Healthcare Ag	Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
MX2008000087A (es) *	2005-06-23	2008-03-18	Schering Corp	Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5.
WO2007039075A2 (en) *	2005-09-29	2007-04-12	Bayer Healthcare Ag	Pde inhibitors and combinations thereof for the treatment of urological disorders
CA2689638A1 (en) *	2007-06-13	2008-12-18	Bayer Schering Pharma Aktiengesellschaft	Pde inhibitors for the treatment of hearing impairment
JP2011524366A (ja) *	2008-06-13	2011-09-01	ロクスロ・ファーマ・インコーポレイテッド	鼻内投与のためのケトロラクの薬学的処方物
US8277781B2 (en) *	2009-03-13	2012-10-02	Luitpold Pharmaceuticals, Inc.	Device for intranasal administration
US8551454B2 (en) *	2009-03-13	2013-10-08	Luitpold Pharmaceuticals, Inc.	Device for intranasal administration
WO2017168174A1 (en)	2016-04-02	2017-10-05	N4 Pharma Uk Limited	New pharmaceutical forms of sildenafil
WO2020006606A1 (en) *	2018-07-05	2020-01-09	Helium 3 Resources Pty Ltd	A pharmaceutical composition and method of use of same
SE542968C2 (en) *	2018-10-26	2020-09-22	Lindahl Anders	Treatment of osteoarthritis
AU2021280285A1 (en) *	2020-05-26	2023-02-02	Strategic Drug Solutions, Inc.	Formulations and methods for treating erectile dysfunction

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4602099A (en) *	1973-04-02	1986-07-22	Merrell Dow Pharmaceuticals Inc.	Antirhinovirus agents
GB9013750D0 (en)	1990-06-20	1990-08-08	Pfizer Ltd	Therapeutic agents
GB9311920D0 (en)	1993-06-09	1993-07-28	Pfizer Ltd	Therapeutic agents
GB9514465D0 (en)	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
GB9514473D0 (en)	1995-07-14	1995-09-13	Glaxo Lab Sa	Chemical compounds
ATE236156T1 (de)	1996-05-31	2003-04-15	Mochida Pharm Co Ltd	Pyridocarbazol derivate die einen cgmp-pde inhibilierenden effekt haben
GB2315673A (en) *	1996-08-01	1998-02-11	Merck & Co Inc	Treatment of migraine
AU739417B2 (en) *	1997-05-29	2001-10-11	Mochida Pharmaceutical Co., Ltd.	Therapeutic agent for erection dysfunction
AU9214498A (en)	1997-09-23	1999-04-12	Eli Lilly And Company	Treatment of attention-deficit/hyperactivity disorder
DK1174431T3 (da)	1997-11-12	2012-08-20	Bayer Pharma AG	2-phenyl-substitueret imidazo triazinon som phoshodiesterase-inhibitorer
TWI223598B (en) *	1998-06-22	2004-11-11	Pfizer Ireland Pharmaceuticals	An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
WO2000000199A1 (en) *	1998-06-26	2000-01-06	Nastech Pharmaceutical Company, Inc.	Nasal delivery of sildenafil citrate
AU764921B2 (en) *	1998-12-14	2003-09-04	Cellegy Pharmaceuticals, Inc.	Compositions and methods for the treatment of anorectal disorders

2001
- 2001-04-12 DE DE10118306A patent/DE10118306A1/de not_active Withdrawn
2002
- 2002-04-03 HU HU0303877A patent/HUP0303877A3/hu unknown
- 2002-04-03 RU RU2003133143/15A patent/RU2003133143A/ru not_active Application Discontinuation
- 2002-04-03 CA CA002443639A patent/CA2443639A1/en not_active Abandoned
- 2002-04-03 KR KR10-2003-7013280A patent/KR20030087072A/ko not_active Withdrawn
- 2002-04-03 JP JP2002581429A patent/JP2004525968A/ja active Pending
- 2002-04-03 EE EEP200300501A patent/EE200300501A/xx unknown
- 2002-04-03 IL IL15825502A patent/IL158255A0/xx unknown
- 2002-04-03 EP EP02732548A patent/EP1381368A2/de not_active Withdrawn
- 2002-04-03 PL PL02363033A patent/PL363033A1/xx not_active Application Discontinuation
- 2002-04-03 WO PCT/EP2002/003663 patent/WO2002083674A2/de not_active Ceased
- 2002-04-03 BR BR0208813-4A patent/BR0208813A/pt not_active Application Discontinuation
- 2002-04-03 CZ CZ20032752A patent/CZ20032752A3/cs unknown
- 2002-04-03 CN CNA028114574A patent/CN1537004A/zh active Pending
- 2002-04-03 SK SK1268-2003A patent/SK12682003A3/sk unknown
- 2002-04-03 MX MXPA03009314A patent/MXPA03009314A/es unknown
- 2002-04-04 DO DO2002000373A patent/DOP2002000373A/es unknown
- 2002-04-10 AR ARP020101322A patent/AR035821A1/es not_active Application Discontinuation
- 2002-04-11 UY UY27256A patent/UY27256A1/es not_active Application Discontinuation
- 2002-04-11 US US10/122,694 patent/US6740306B2/en not_active Expired - Fee Related
- 2002-04-11 GT GT200200070A patent/GT200200070A/es unknown
- 2002-04-11 PE PE2002000303A patent/PE20021035A1/es not_active Application Discontinuation
2003
- 2003-10-08 EC EC2003004795A patent/ECSP034795A/es unknown
- 2003-10-09 BG BG108245A patent/BG108245A/xx unknown
- 2003-10-10 NO NO20034556A patent/NO20034556L/no not_active Application Discontinuation
2004
- 2004-03-30 US US10/813,801 patent/US20040248891A1/en not_active Abandoned

Also Published As

Publication number	Publication date
MXPA03009314A (es)	2004-03-10
US6740306B2 (en)	2004-05-25
WO2002083674A3 (de)	2003-01-09
HUP0303877A2 (hu)	2004-03-29
DOP2002000373A (es)	2002-11-30
UY27256A1 (es)	2002-11-29
EP1381368A2 (de)	2004-01-21
AR035821A1 (es)	2004-07-14
SK12682003A3 (sk)	2004-03-02
BR0208813A (pt)	2004-03-09
WO2002083674A2 (de)	2002-10-24
CZ20032752A3 (cs)	2004-01-14
GT200200070A (es)	2003-01-31
CA2443639A1 (en)	2002-10-24
IL158255A0 (en)	2004-05-12
HUP0303877A3 (en)	2005-05-30
JP2004525968A (ja)	2004-08-26
ECSP034795A (es)	2003-12-01
CN1537004A (zh)	2004-10-13
PL363033A1 (en)	2004-11-15
PE20021035A1 (es)	2002-11-29
BG108245A (en)	2005-01-31
NO20034556D0 (no)	2003-10-10
RU2003133143A (ru)	2005-04-10
US20030022894A1 (en)	2003-01-30
DE10118306A1 (de)	2002-10-17
EE200300501A (et)	2003-12-15
US20040248891A1 (en)	2004-12-09
KR20030087072A (ko)	2003-11-12

Publication	Publication Date	Title
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
EP1466610A4 (en)	2007-03-21	MEDICAL COMPOSITIONS FOR RECEIVING VIA THE NOSE
EE05581B1 (et)	2012-10-15	Aripiprasooli ravimlahus peroraalseks manustamiseks
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
NO20033384D0 (no)	2003-07-29	Farmasöytisk formulering
EE200300416A (et)	2003-12-15	Ravimvorm
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
IS7051A (is)	2003-11-26	Lyfjasamsetningar
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20034556L (no)	2003-12-10	Imidazotriazinon-holdige sammensetninger for nasal administrering
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
NO20040860L (no)	2004-04-22	Farmasoytisk sammensetning som innbefatter lumiracoxib
DE50209245D1 (de)	2007-02-22	Neuroprotektives medikament
NO20031095D0 (no)	2003-03-10	Farmasöytiske sammensetninger
NO20020524L (no)	2002-08-02	Stabiliserte organisk-peroksid sammensetninger
EE200300465A (et)	2003-12-15	Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS
FI20012242A0 (fi)	2001-11-19	Uudet farmaseuttiset yhdisteet
EE200200689A (et)	2004-06-15	Ravimkoostised
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus
NO20041236L (no)	2004-03-24	Farmasoytisk formulering
SE0100847D0 (sv)	2001-03-09	Novel pharmaceutical composition

Legal Events

Date	Code	Title	Description
2005-11-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application